Insider Transactions

Date	Name	Title	Type	Shares Traded	Price Range
Nov 14, 2008	adelman robert j	Director	Buy	1,214,646	n/a
Nov 13, 2007	adelman robert j	Director	Acquisition (Non Open Market)	1,825,493	n/a
Nov 13, 2007	adelman robert j	Director	Buy	300,000	10.00
Nov 7, 2007	barker jason	Officer	Statement of Ownership	0	n/a
Nov 14, 2008	baskett forest	Beneficial Owner (10% or more)	Statement of Ownership	0	n/a
Nov 14, 2008	drant ryan d	Beneficial Owner (10% or more)	Statement of Ownership	0	n/a
Aug 17, 2009	druzgala pascal	Officer	Disposition (Non Open Market)	17,964	n/a
Oct 27, 2008	druzgala pascal	Officer	Disposition (Non Open Market)	15,368	n/a
Nov 13, 2007	druzgala pascal	Officer	Acquisition (Non Open Market)	1,122	n/a
Nov 7, 2007	druzgala pascal	Officer	Statement of Ownership	0	n/a
Nov 7, 2007	druzgala pascal	Officer	Statement of Ownership	0	n/a
Nov 14, 2008	evnin luke	Beneficial Owner (10% or more)	Buy	1,787,710	2.20
Nov 13, 2007	evnin luke	Beneficial Owner (10% or more)	Buy	300,000	10.00
Nov 13, 2007	evnin luke	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	3,276,862	n/a
Nov 13, 2007	goddard paul	Officer	Acquisition (Non Open Market)	3,021	n/a
Nov 7, 2007	goddard paul	Officer	Statement of Ownership	0	n/a
Nov 7, 2007	goddard paul	Officer	Statement of Ownership	0	n/a
Nov 14, 2008	Growth Equity Opportunities fund, llc	Beneficial Owner (10% or more)	Statement of Ownership	0	n/a
Nov 14, 2008	kerins patrick j	Beneficial Owner (10% or more)	Statement of Ownership	0	n/a
Nov 14, 2008	kolluri krishna kittu	Beneficial Owner (10% or more)	Statement of Ownership	0	n/a
Showing 1-20 of 38 transactions Page: 1 2  See Next 20

Stock transaction information provided by EDGAR Online. ARYx Therapeutics makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.